Megakaryocyte induced fibroblast proliferation is enhanced by costimulation with IL-6/IL-3 and dependent on secretory and adhesion events

Leukemia Research

Volumn 23, Issue 8, 1999, Pages 723-729

  Schmitz, Beate ^a   Wickenhauser, Claudia ^a   Thiele, Juergen ^a   Frimpong, Semra ^a   Brockbals, Carina ^a   Selbach, Barbara ^a   Mueller, Cornelia ^a   Fischer, Robert ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Fibroblast proliferation; IL 3; IL 6; Megakaryocyte fiibroblast interaction

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; PLATELET DERIVED GROWTH FACTOR; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL ADHESION; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

CELL ADHESION; CELL DIVISION; COCULTURE TECHNIQUES; FIBROBLASTS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; MEGAKARYOCYTES; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032808021     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00091-0     Document Type: Article

References (56)

1. Kittler E.L.W., McGrath H., Temeless D., Crittenden R.B., Kister V.K., Quesenberry J. Biologic significance of constitutive and subliminal growth factor production by bone marrow stroma. Blood. 79:1992;3168.
2. Rohde D., Wickenhauser C., Denecke S., Stach A., Lorenzen J., Hansmann M.L., Thiele J., Fischer R. Cytokine release by bone marrow cells: analysis at the single cell level. Virchows. Archiv. 424:1994;389.
3. Wickenhauser C., Lorenzen J., Thiele J., Hillienhof A., Jungheim K., Schmitz B., Hansmann M.L., Fischer R. Secretion of cytokines (IL-1α, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood. 85:1995;685.
4. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 82:1993;3515.
5. Olsson I., Gullberg U., Lantz M., Richter J. The receptors for regulatory molecules of hematopoiesis. Eur. J. Haematol. 48:1992;1.
6. Hawley R.G. Hematopathology of interleukin 6-type cytokines. Stem. Cells. 12:1994;155.
7. Kishimoto T. The biology of interleukin-6. Blood. 74:1989;1.
8. Kishimoto T., Toya T., Akira S. Cytokine signal transduction. Cell. 76:1994;253.
9. Hoffmann R. Regulation of megakaryopoiesis. Blood. 74:1989;1196.
10. Kauskansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 86:1995;419.
11. Debili N., Massé J.M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood. 82:1993;84.
12. Navarro S., Debili N., Le Couedic J.P., Klein B., Breton-Gorius J., Doly J., Vainchenker W. Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood. 77:1991;461.
13. Fuse A., Kakuda H., Shima Y., van Damme J., Billiau A., Sato T. Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br. J. Haematol. 77:1991;32.
14. Avraham H., Vannier E., Chi S.Y., Dinarello C.A., Groopman J.E. Cytokine gene expression and synthesis by human megakaryocytes. Int. J. Cell. Cloning. 10:1992;70.
15. Chen Z.Y., Gu X.F., Caen J.P., Han Z.C. Interleukin-3 is an autocrine growth factor of human megakaryocytes, the DAMI and the MEG-01 cells. Br. J. Haematol. 88:1994;481.
16. Wickenhauser C., Hillienhof A., Jungheim C., Lorenzen J., Ruskowski H., Hansmann M.L., Thiele J., Fischer R. Detection and quantification of transforming growth factor ( and platelet-derived growth factor release by normal human megakaryocytes. Leukemia. 9:1995;310.
17. Castro-Malaspina H., Rabellino E.M., Yen A., Nachman R.L., Moore M.A.S. Human megakaryocyte stimulation of bone marrow fibroblasts. Blood. 57:1981;781.
18. Schmitz B., Thiele J., Kaufmann R., Witte O., Wickenhauser C., Kuhn-Regnier F., Fischer R. Megakaryocytes and fibroblasts-interactions determined in normal human bone marrow specimens. Leuk. Res. 19:1995;629.
19. Schmitz B., Thiele J., Witte O., Kaufmann R., Wickenhauser C., Fischer R. Influence of cytokines (IL-1α, IL-3, IL-11, GM-CSF) on megakaryocyte-fibroblast interactions in normal human bone marrow. Eur. J. Haematol. 55:1995;24.
20. Schmitz B., Thiele J., Otto F., Theile-Ochel S., Heedt T., Zensen U., Baldus S.E., Wickenhauser C., Fischer R. Interactions between endogeneous lectins and fucosylated oligosaccharids in megakaryocyte-dependent fibroblast growth of the normal bone marrow. Leukemia. 10:1996;1604.
21. Schmitz B., Thiele J., Otto F., Farahmand P., Henze F., Frimpong S., Wickenhauser C., Fischer R. Evidence for integrin receptor involvement in megakaryocyte-fibroblast interaction-a possible pathomechanism for the evolution of myelofibrosis. J. Cell Physiol.; 176. 1998:1998;445.
22. Martyré M.C., Romquin N., Bousse-Kerdiles M.C., Chewillard S., Benyahia B., Dupriez B., Demory J.L., Bauters F. Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br. J. Haematol. 88:1994;9.
23. Martyré M.C. TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk. Lymph. 20:1995;39.
24. Michiel D.F., Oppenheim J.J. Cytokines as positive and negative regulators of tumor promotion and progression. Semin. Cancer. Biol. 3:1992;3.
25. Puztai L., Lewis C.E., Lorenzen J., O'D McGee J. Growth factors: regulation of normal and neoplastic growth. J. Pathol. 169:1993;191.
26. Schmitz B., Radbruch A., Kümmel T., Wickenhauser C., Korb H., Hansmann M.L., Thiele J., Fischer R. Magnetic activated cell sorting (MACS)-a new immunological method for megakaryocytic cell isolation: comparison of different separation techniques. Eur. J. Haematol. 52:1994;267.
27. Gatter K.C., Cordell J.L., Turley H., Heryet A., Kieffer N., Anstee D.J., Mason D.Y. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology. 13:1988;257.
28. Debili N., Issaad C., Masse J.M., Giuchard I., Katz A., Breton-Gorius J., Vainchainker W. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 80:1992;3022.
29. Schmitz B., Park I.A., Kaufmann R., Thiele J., Fischer R. Influence of cytokine stimulation (granulocyte macrophage-colony stimulating factor, interleukin-3, and transforming growth factor-beta-1) on adhesion molecule expression in normal human bone marrow fibroblasts. Acta Haematol. Basel. 94:1995;173.
30. Tomer A., Harker L.A., Burstein S.A. Purification of human megakaryocytes by fluorescence-activated cell sorting. Blood. 70:1987;1735.
31. Briddell R.A., Brandt J.E., Leemhuis T.B., Hoffman R. Role of cytokines in sustaining long-term human megakaryopoiesis in vitro. Blood. 79:1992;332.
32. Lemoli R.M., Gulati S.C. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Stem. Cells. 11:1993;435.
33. Ishibashi T., Kimura H., Uchida T., Kariyone S., Friese P., Burstein S.A. Human interleukin 6 is a direct promotor of maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci. USA. 86:1989;5953.
34. Bruno E., Hoffman R. Effect of interleukin 6 on in vitro human megakaryopoiesis: its interaction with other cytokines. Exp. Hematol. 17:1989;1038.
35. Bruno E., Cooper R.J., Briddell R.A., Hoffman R. Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocyte progenitor cells. Blood. 77:1991;2339.
36. Ikebushi K., Wong G.G., Clark S.C., Ihle J.N., Hirai T., Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotent hemopoietic progenitors. Proc. Natl. Acad. Sci. USA. 84:1987;9035.
37. Koike K., Nakahata T., Tagaki M., Kobayashi T., Ishigura A., Tsuji K., Naganuma K., Okano A., Akiyama Y., Akabene T. Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture. J. Exp. Med. 168:1988;879-890.
38. Avraham H., Banu N., Scadden D.T., Abraham J., Groopman J.E. Modulation of egakaryopoiesis by human basic fibroblast growth factor. Blood. 83:1994;2126.
39. Bruno E., Cooper R.J., Wilson E.L., Gabrilove J.L., Hoffman R. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood. 82:1993;430.
40. Guba S.C., Sartor C.I., Gottschalk L.R., Ye-Hu J., Mulligan T., Emerson S.G. Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood. 80:1992;1190.
41. Bikfalvi A., Han Z.C., Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytic-like cells. Blood. 80:1992;1905.
42. Ignatz R.A., Massagué J. Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell. 51:1987;189.
43. Kinashi T., Springer T.A. Regulation of cell-matrix adhesion by receptor tyrosine kinases. Leuk. Lymph. 18:1995;203.
44. Hardy C.L., Minguell J.J. Modulation of the adhesion of hemapoietic progenitor cells to the RGD site of fibronectin by interleukin 3. J. Cell Physiol. 164:1995;315.
45. Avraham H., Cowley S., Chi S.Y., Jiang S., Groopman J.E. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J. Clin. Invest. 91:1994;2378.
46. Bendall L.J., Kortlepel K., Gottlieb D.J. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-α and interferon-γ increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism. Exp. Hematol. 25:1997;132.
47. Thiele J., Fischer R. Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. Virchows Archiv. A Pathol. Anat. 418:1991;81.
48. Ellis J.T., Peterson P., Geller S.A., Rappaport H. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin. Hematol. 23:1986;144.
49. Bilgrami S., Greenberg B.R. Polycythemia rubra vera. Semin. Oncol. 22:1995;307.
50. Reilly J.T. Pathogenesis of idiopathic myelofibrosis: role of growth factors. J. Clin. Pathol. 45:1992;461.
51. Wickenhauser C., Thiele J., Lorenzen J., Schmitz B., Frimpong S., Schramm K., Neumann I., Zankovich R., Fischer R. Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6. Leukemia (in press).
52. Wang J.C., Chen C., Mora M. Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid leukemia. Leukemia. 11:1997;1827.
53. Kobayashi S., Teramura M., Hoshino S., Motoji T., Oshimi K., Mizoguchi H. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3. Br. J. Haematol. 83:1993;539.
54. Dai C.H., Krantz S.B., Dessypris E.N., Means Jr R.T., Horn S.T., Gilbert H.S. Polycythemia vera. II. Hypersenitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood. 80:1992;891.
55. Bhatia R., McGlave P.B., Dewald G.W., Blazar B.R., Verfaillie C.M. Abnormal function of the bone marrow microenvironment in chronic myelogeneous leukemia: role of malignant stromal macrophages. Blood. 85:1995;3636.
56. Schirmacher P., Peters M., Ciliberto G., Blessing M., Lotz J., Meyer zum Büschenfelde K.H., Rose John S. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/ soluble IL-6 receptor double-transgenic mice. Am. J. Pathol. 153:1998;639.